You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

skin cancer risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma and Other Malignant Tumors of Skin Trial in New Brunswick (UV4.me2, UV4.me, E-Pamphlet)

Completed
  • Melanoma and Other Malignant Neoplasms of Skin
  • UV4.me2
  • +2 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Non-Melanoma Skin Cancer Risk

Active, not recruiting
  • Skin Cancer, Non-Melanoma
    • Birmingham, Alabama
      The Kirklin Clinic
    Aug 12, 2022

    Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum

    Recruiting
    • Xeroderma Pigmentosum
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Skin Cancer Trial in Salt Lake City (Education, Action Plan, UV Photo)

      Not yet recruiting
      • Skin Cancer
      • Education
      • +3 more
      • Salt Lake City, Utah
        Huntsman Cancer Institute
      Dec 1, 2022

      Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,

      Recruiting
      • Recurrent Skin Squamous Cell Carcinoma
      • +4 more
      • Cemiplimab
      • Resection
      • Los Angeles, California
      • +2 more
      Nov 12, 2022

      Non-melanoma Skin Cancer Trial in Birmingham (UAB30, Placebo)

      Recruiting
      • Non-melanoma Skin Cancer
      • Birmingham, Alabama
        UAB Dermatology
      Aug 30, 2022

      TLR4 Polymorphisms and Risk of Skin Cancer

      Active, not recruiting
      • Skin Cancer
      • Detection of single nucleotide polymorphisms (SNP)
      • Birmingham, Alabama
        The Kirklin Clinic
      Jan 20, 2022

      Breast Carcinoma Trial in Ghent (radiation in prone position, radiation in supine position)

      Completed
      • Breast Carcinoma
      • radiation in prone position
      • radiation in supine position
      • Ghent, Belgium
        University Hospital Ghent
      Dec 15, 2022

      Dysplastic Nevus, Health Status Unknown, Melanoma Trial in New Brunswick (Best Practice, mySmartCheck, Survey Administration)

      Completed
      • Dysplastic Nevus
      • +3 more
      • Best Practice
      • +2 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Apr 5, 2022

      Disease-free Survival of High-risk Head-neck Cutaneous Squamous

      Active, not recruiting
      • Carcinoma, Squamous Cell
      • +5 more
      • Treatment
      • Maastricht, Netherlands
      • +1 more
      Apr 26, 2023

      Melanoma, Skin Cancer, Anxiety and Fear Trial in Australia (2D or 3D Melanoma Surveillance Photography)

      Recruiting
      • Melanoma
      • +2 more
      • 2D or 3D Melanoma Surveillance Photography
      • Camperdown, New South Wales, Australia
      • +11 more
      Aug 22, 2022

      Seroma of the Mammary Gland

      Not yet recruiting
      • Seroma
      • +3 more
      • Swap collection
      • +2 more
      • (no location specified)
      Jun 1, 2023

      Melanoma Trial in Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

      Recruiting
      • Melanoma
      • Knoxville, Tennessee
        University of Tennessee Medical Center
      Dec 20, 2022

      Needs and Preferences of Patients With Head-neck Cutaneous SCC

      Active, not recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +10 more
      • Regular care with additional administration of a semi-structured interview
      • Maastricht, Netherlands
        Maastricht University Medical Center+
      Sep 13, 2023

      Melanoma, Young Adult Trial in Salt Lake City (diagnostic test, other, device)

      Completed
      Has Results
      • Melanoma
      • Young Adult
      • MC1R Genetic Testing
      • +2 more
      • Salt Lake City, Utah
        Huntsman Cancer Institute
      Jul 9, 2021

      Risk Factors for Shoulder Joint Motion Restriction

      Not yet recruiting
      • Breast Cancer Survivors
      • measurement of tissue stiffness (N/m)
      • +7 more
      • Istanbul, Turkey
        İstanbul Medeniyet University
      May 25, 2022

      Decisional Conflicts, Health-related QoL and Satisfaction With

      Recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +9 more
      • Regular care with additionally administration of questionnaires
      • Nijmegen, Gelderland, Netherlands
      • +1 more
      Jul 28, 2022

      Melanoma (Skin), Nevus, Nevus, Spitz Trial in Moscow, Nizhny Novgorod (Mobile phone application "ProRodinki")

      Recruiting
      • Melanoma (Skin)
      • +9 more
      • Mobile phone application "ProRodinki"
      • Moscow, Russian Federation
      • +1 more
      May 29, 2022

      Lung Cancer, Nonsmall Cell, Renal Cell Carcinoma, Melanoma Trial in Sydney (Blood screening, Tissue screening)

      Recruiting
      • Lung Cancer, Nonsmall Cell
      • +6 more
      • Blood screening
      • Tissue screening
      • Sydney, New South Wales, Australia
      • +1 more
      Jan 19, 2022

      Melanoma (Skin) Trial in Salt Lake City (Aspirin 81 mg, Aspirin 325mg)

      Completed
      • Melanoma (Skin)
      • Aspirin 81 mg
      • Aspirin 325mg
      • Salt Lake City, Utah
        Huntsman Cancer Institute/University of Utah
      Feb 16, 2022

      MDS Trial in Tampa, Saint Louis, Seattle (CPX-351, Research skin biopsy, Research blood draw)

      Active, not recruiting
      • Myelodysplastic Syndromes
      • Tampa, Florida
      • +2 more
      Apr 1, 2022

      Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +5 more
      • Jacksonville, Florida
      • +2 more
      Oct 21, 2022

      Hydrochlorothiazide and Risk of Skin Cancer

      Completed
      • Non-melanoma Skin Cancer
      • +2 more
      • Montreal, Quebec, Canada
        Centre for Clinical Epidemiology, Lady Davis Institute, Jewish G
      Mar 8, 2021

      Melanoma (Skin) Trial in Salt Lake City (Aspirin 81 mg, Aspirin 325mg, Placebo oral tablet)

      Completed
      • Melanoma (Skin)
      • Aspirin 81 mg
      • +2 more
      • Salt Lake City, Utah
        Huntsman Cancer Institute/University of Utah
      Feb 16, 2022

      Breast Cancer Trial in Milano (skin reducing mastectomy)

      Completed
      • Breast Cancer
      • skin reducing mastectomy
      • Milano, Lombardia, Italy
        Istituto Europeo di Oncologia
      Nov 10, 2023